AstraZeneca PLC (NYSE:AZN)

72.59
Data as of Aug 01
 -0.20 / -0.27%
Today’s Change
48.54
Today|||52-Week Range
82.68
+22.27%
Year-to-Date
Nektar's Loss Narrows in Q2, Beats Revenues, Retains View - Analyst Blog
Aug 01 / Zacks.com
Pfizer Beats on Q2 Earnings, Revs Despite Generic Pressures - Analyst Blog
Jul 29 / Zacks.com
Teva's Q2 Earnings & Revs Grow Y/Y, Updates Outlook - Analyst Blog
Aug 01 / Zacks.com
Novo Nordisk Diabetes Drug Xultophy Gets Positive CHMP View - Analyst Blog
Jul 29 / Zacks.com
Valeant Pharmaceuticals Earnings Up Y/Y, View Lowered - Analyst Blog
Aug 01 / Zacks.com
Why Horizon Pharmaceuticals (HZNP) Is Plummeting Today
Jul 28 / TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape
Aug 01 / Zacks.com
Bristol-Myers (BMY) Beats on Q2 Earnings, Maintains Outlook - Analyst Blog
Jul 24 / Zacks.com
Sanofi Beats on Q2 Earnings, View Up on Strong Performance - Analyst Blog
Aug 01 / Zacks.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews
Jul 24 / Zacks.com
AstraZeneca (AZN) Beats on Q2 Earnings, Guidance Raised - Analyst Blog
Aug 01 / Zacks.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
Jul 24 / Zacks.com
McKesson Beats on Q1 Earnings & Revenues, Increases Guidance - Analyst Blog
Jul 31 / Zacks.com
Glaxo (GSK) Slips on Disappointing Q2 Earnings, Cuts View - Analyst Blog
Jul 24 / Zacks.com
3 Eye-Catching Health Care Stocks this Earnings Season - Earnings ESP
Jul 31 / Zacks.com
Johnson & Johnson Announces $5B Share Buyback - Analyst Blog
Jul 22 / Zacks.com
Tax Inversion: Boon for Firms & Investors, Bane for U.S. Treasury - Analyst Blog
Jul 31 / Zacks.com
Allergan, a Valeant Takeover Target, Plans 1,500 Job Cuts - Analyst Blog
Jul 22 / Zacks.com
Stocks Mixed Despite Better-Than-Expected GDP
Jul 30 / Benzinga
Income Investing by the Poolside
Jul 22 / MotleyFool.com
Merck & Co., Inc. (MRK) & Pfizer Inc. (PFE): Expectations For The Biopharma Giants
Jul 30 / Investing Channel
Tuesdaybs Top Health Care Stocks: Herbalife, Exact Sciences, AstraZeneca, J&J
Jul 22 / MotleyFool.com
Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay?
Jul 30 / TheStreet.com
Allergan Beats on Q2 Earnings, Ups View & Plans 13% Job Cut - Analyst Blog
Jul 21 / Zacks.com
Stock Market Today: Stocks Slip Ahead of Fed Policy Announcement
Jul 30 / TheStreet.com
Drugmaker in $54.7 billion merger aimed at cutting U.S. taxes
Jul 18 / CNNMoney.com
Stock Market Today: Futures Rise Ahead of GDP, Fed; Twitter Shares Soar
Jul 30 / TheStreet.com
Lew: Stop firms moving abroad to dodge tax
Jul 16 / CNNMoney.com
Why AstraZeneca (AZN) Stock Is Up Today
Jul 30 / TheStreet.com
Drug maker willing to pay more to escape U.S. tax
Jul 14 / CNNMoney.com
July 30 Premarket Briefing: 10 Things You Should Know
Jul 30 / TheStreet.com
Stocks: 5 things to know before the open
Jul 14 / CNNMoney.com
European Stocks Steady as Barclays Reports, AstraZeneca Buys Generic Line
Jul 30 / TheStreet.com
More companies bail on U.S. for lower taxes
Jul 07 / CNNMoney.com
IPXL, HLF And AZN, Pushing Drugs Industry Downward
Jul 29 / TheStreet.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.